{'52WeekChange': -0.6872587,
 'SandP52WeekChange': None,
 'address1': '4105 Hopson Road',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 0.8744,
 'askSize': 2900,
 'averageDailyVolume10Day': 88491475,
 'averageVolume': 25610931,
 'averageVolume10days': 88491475,
 'beta': -0.258198,
 'beta3Year': None,
 'bid': 0.8741,
 'bidSize': 1000,
 'bookValue': -0.172,
 'category': None,
 'circulatingSupply': None,
 'city': 'Morrisville',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1,
 'dayLow': 0.7202,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -2.589,
 'enterpriseToRevenue': 14.807,
 'enterpriseValue': 74166472,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 0.5642857,
 'fiftyTwoWeekHigh': 3.72,
 'fiftyTwoWeekLow': 0.215,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 59208813,
 'forwardEps': -0.17,
 'forwardPE': -5.0535293,
 'fromCurrency': None,
 'fullTimeEmployees': 28,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.18202999,
 'heldPercentInstitutions': 0.09834,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/novan.com',
 'longBusinessSummary': 'Novan, Inc., a clinical development-stage '
                        'biotechnology company, focuses on the development and '
                        'commercialization of nitric oxide-based therapies to '
                        'treat dermatological and oncovirus-mediated diseases. '
                        'Its clinical stage dermatology product candidates '
                        'include SB204, a topical monotherapy for the '
                        'treatment of acne vulgaris; SB206, a topical '
                        'anti-viral gel for the treatment of viral skin '
                        'infections; SB208, a topical broad-spectrum '
                        'anti-fungal gel for the treatment of fungal '
                        "infections of the skin and nails, including athlete's "
                        'foot and fungal nail infections; and SB414, a topical '
                        'cream-based product candidate for the treatment of '
                        'inflammatory skin diseases. The company also develops '
                        'SB207, a topical anti-viral product candidate. Novan, '
                        'Inc. has a license agreement with Sato Pharmaceutical '
                        'Co., Ltd.; and a strategic alliance with Orion '
                        'Corporation. The company was founded in 2006 and is '
                        'headquartered in Morrisville, North Carolina.',
 'longName': 'Novan, Inc.',
 'market': 'us_market',
 'marketCap': 110155520,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_115977469',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -30171000,
 'nextFiscalYearEnd': 1640908800,
 'open': 0.7477,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '919 485 8080',
 'previousClose': 0.81,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 21.99152,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1,
 'regularMarketDayLow': 0.7202,
 'regularMarketOpen': 0.7477,
 'regularMarketPreviousClose': 0.81,
 'regularMarketPrice': 0.7477,
 'regularMarketVolume': 77024023,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 80786400,
 'sharesPercentSharesOut': 0.0372,
 'sharesShort': 3001461,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1514254,
 'shortName': 'Novan, Inc.',
 'shortPercentOfFloat': 0.0377,
 'shortRatio': 0.11,
 'startDate': None,
 'state': 'NC',
 'strikePrice': None,
 'symbol': 'NOVN',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.04,
 'twoHundredDayAverage': 0.48819426,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '4fde42ba-2a97-3016-bc51-3a8f1f70e238',
 'volume': 77024023,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.novan.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '27560'}